Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

China flag China · Delayed Price · Currency is CNY
2.900
+0.010 (0.35%)
Jun 12, 2026, 3:04 PM CST
Market Cap5.50B -19.0%
Revenue (ttm)5.44B -7.6%
Net Income127.70M +52.4%
EPS0.07 +51.7%
Shares Out 1.90B
PE Ratio43.04
Forward PEn/a
Dividend0.09 (3.10%)
Ex-Dividend DateMay 21, 2026
Volume27,471,912
Open2.900
Previous Close2.890
Day's Range2.880 - 2.950
52-Week Range2.830 - 4.150
Beta0.20
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:002390

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological medications, and anti-infective drugs. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China. [Read more]

Sector Healthcare
Founded 1995
Employees 4,702
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2025, SHE:002390's revenue was 5.62 billion, a decrease of -6.84% compared to the previous year's 6.03 billion. Earnings were 120.29 million, an increase of 18.65%.

Financial Statements